160 related articles for article (PubMed ID: 11298352)
1. Protection and injury: the differing roles of complement in the development of glomerular injury.
Sheerin NS; Springall T; Abe K; Sacks SH
Eur J Immunol; 2001 Apr; 31(4):1255-60. PubMed ID: 11298352
[TBL] [Abstract][Full Text] [Related]
2. Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice.
Wakayama H; Hasegawa Y; Kawabe T; Hara T; Matsuo S; Mizuno M; Takai T; Kikutani H; Shimokata K
Eur J Immunol; 2000 Apr; 30(4):1182-90. PubMed ID: 10760808
[TBL] [Abstract][Full Text] [Related]
3. Nephritogenic potential of sheep antibodies against glomerular basement membrane laminin in the rat.
Feintzeig ID; Abrahamson DR; Cybulsky AV; Dittmer JE; Salant DJ
Lab Invest; 1986 May; 54(5):531-42. PubMed ID: 3517487
[TBL] [Abstract][Full Text] [Related]
4. Altered distribution of intraglomerular immune complexes in C3-deficient mice.
Sheerin NS; Springall T; Carroll M; Sacks SH
Immunology; 1999 Jul; 97(3):393-9. PubMed ID: 10447759
[TBL] [Abstract][Full Text] [Related]
5. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice.
Sheerin NS; Springall T; Carroll MC; Hartley B; Sacks SH
Clin Exp Immunol; 1997 Dec; 110(3):403-9. PubMed ID: 9409643
[TBL] [Abstract][Full Text] [Related]
6. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis.
Tang T; Rosenkranz A; Assmann KJ; Goodman MJ; Gutierrez-Ramos JC; Carroll MC; Cotran RS; Mayadas TN
J Exp Med; 1997 Dec; 186(11):1853-63. PubMed ID: 9382884
[TBL] [Abstract][Full Text] [Related]
7. A role for P selectin in complement-independent neutrophil-mediated glomerular injury.
Tipping PG; Huang XR; Berndt MC; Holdsworth SR
Kidney Int; 1994 Jul; 46(1):79-88. PubMed ID: 7523757
[TBL] [Abstract][Full Text] [Related]
8. Concurrent antiglomerular basement membrane antibody and immune complex mediated glomerulonephritis.
Jennette JC; Lamanna RW; Burnette JP; Wilkman AS; Iskander SS
Am J Clin Pathol; 1982 Sep; 78(3):381-6. PubMed ID: 6180630
[TBL] [Abstract][Full Text] [Related]
9. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
[TBL] [Abstract][Full Text] [Related]
10. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
[TBL] [Abstract][Full Text] [Related]
11. Resistance of CD28-deficient mice to autologous phase of anti-glomerular basement membrane glomerulonephritis.
Nitta K; Horita S; Ogawa S; Matsumoto M; Hara Y; Okano K; Hayashi T; Abe R; Nihei H
Clin Exp Nephrol; 2003 Jun; 7(2):104-12. PubMed ID: 14586728
[TBL] [Abstract][Full Text] [Related]
12. Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome.
Pasternack A; Törnroth T; Linder E
Clin Nephrol; 1978 Feb; 9(2):77-85. PubMed ID: 147761
[TBL] [Abstract][Full Text] [Related]
13. Predominant role of FcgammaRIII in the induction of accelerated nephrotoxic glomerulonephritis.
Fujii T; Hamano Y; Ueda S; Akikusa B; Yamasaki S; Ogawa M; Saisho H; Verbeek JS; Taki S; Saito T
Kidney Int; 2003 Oct; 64(4):1406-16. PubMed ID: 12969160
[TBL] [Abstract][Full Text] [Related]
14. Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis.
Thurman JM; Tchepeleva SN; Haas M; Panzer S; Boackle SA; Glogowska MJ; Quigg RJ; Holers VM
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1529-36. PubMed ID: 22492944
[TBL] [Abstract][Full Text] [Related]
15. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.
Heeringa P; van Goor H; Itoh-Lindstrom Y; Maeda N; Falk RJ; Assmann KJ; Kallenberg CG; Jennette JC
Am J Pathol; 2000 Mar; 156(3):879-88. PubMed ID: 10702405
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis.
Sogabe H; Nangaku M; Ishibashi Y; Wada T; Fujita T; Sun X; Miwa T; Madaio MP; Song WC
J Immunol; 2001 Sep; 167(5):2791-7. PubMed ID: 11509624
[TBL] [Abstract][Full Text] [Related]
17. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
Boyce NW; Holdsworth SR
J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
Miettinen A; Stow JL; Mentone S; Farquhar MG
J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
[TBL] [Abstract][Full Text] [Related]
19. Increased susceptibility to immunologically mediated glomerulonephritis in IFN-gamma-deficient mice.
Ring GH; Dai Z; Saleem S; Baddoura FK; Lakkis FG
J Immunol; 1999 Aug; 163(4):2243-8. PubMed ID: 10438967
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune renal injury in C3- and C4-deficient mice: a histological and functional study.
Kouki P; Marsh JE; Sacks SH; Sheerin NS
Nephron Exp Nephrol; 2004; 96(1):e14-22. PubMed ID: 14752244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
